AR115942A2 - STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS - Google Patents
STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERSInfo
- Publication number
- AR115942A2 AR115942A2 ARP190102272A ARP190102272A AR115942A2 AR 115942 A2 AR115942 A2 AR 115942A2 AR P190102272 A ARP190102272 A AR P190102272A AR P190102272 A ARP190102272 A AR P190102272A AR 115942 A2 AR115942 A2 AR 115942A2
- Authority
- AR
- Argentina
- Prior art keywords
- arisulfatase
- pharmaceutical compositions
- stable pharmaceutical
- administration
- containing containers
- Prior art date
Links
Abstract
La presente se refiere a la administración intratecal de enzimas lisosomales para el tratamiento eficaz de enfermedades de almacenamiento lisosomal En algunas formas de realización, la presente proporciona formulaciones estables para la administración IT de Arilsulfatasa A.The present relates to the intrathecal administration of lysosomal enzymes for the effective treatment of lysosomal storage diseases. In some embodiments, the present provides stable formulations for IT administration of Arylsulfatase A.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35885710P | 2010-06-25 | 2010-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR115942A2 true AR115942A2 (en) | 2021-03-17 |
Family
ID=75905105
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190102272A AR115942A2 (en) | 2010-06-25 | 2019-08-09 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS |
ARP210101255A AR122036A2 (en) | 2010-06-25 | 2021-05-07 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A |
ARP210103195A AR124100A2 (en) | 2010-06-25 | 2021-11-18 | PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES |
ARP210103544A AR124399A2 (en) | 2010-06-25 | 2021-12-16 | STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210101255A AR122036A2 (en) | 2010-06-25 | 2021-05-07 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A |
ARP210103195A AR124100A2 (en) | 2010-06-25 | 2021-11-18 | PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES |
ARP210103544A AR124399A2 (en) | 2010-06-25 | 2021-12-16 | STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE |
Country Status (1)
Country | Link |
---|---|
AR (4) | AR115942A2 (en) |
-
2019
- 2019-08-09 AR ARP190102272A patent/AR115942A2/en unknown
-
2021
- 2021-05-07 AR ARP210101255A patent/AR122036A2/en unknown
- 2021-11-18 AR ARP210103195A patent/AR124100A2/en unknown
- 2021-12-16 AR ARP210103544A patent/AR124399A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR124399A2 (en) | 2023-03-22 |
AR122036A2 (en) | 2022-08-03 |
AR124100A2 (en) | 2023-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR081678A1 (en) | METHODS AND COMPOSITIONS FOR INTRATECAL ADMINISTRATION OF ARISULFATASE A | |
CY1124910T1 (en) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLOSULFATASE A | |
NZ717728A (en) | Stable formulations of a hyaluronan-degrading enzyme | |
MX352823B (en) | Protein formulations containing amino acids. | |
IN2012DN06720A (en) | ||
BR112014004460A2 (en) | polymeric material for an insulated container | |
MA38096A1 (en) | Stable mydriatic and anti-inflammatory solutions without preservatives to be injected | |
PE20150762A1 (en) | ETANERCEPT FORMULATIONS SHOWING A MARKED REDUCTION IN THE AMOUNT OF SUBVISIBLE PARTICLES | |
BR112012032008A2 (en) | s100a4 antibodies and therapeutic uses thereof | |
GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
TN2013000386A1 (en) | Suspension type topical formulations comprising cyclic depsipeptide | |
AR082215A1 (en) | PHARMACEUTICAL COMPOSITION NICE TO THE PALATE | |
TR201009167A2 (en) | Pharmaceutical granules containing cephalosporin. | |
MX2014006574A (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same. | |
AR115942A2 (en) | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS | |
IN2014CN04119A (en) | ||
ECSP13012765A (en) | COMBINATION AND COMPOSITION FOR OBESITY TREATMENT | |
CO6751242A2 (en) | Combination and composition for the treatment of obesity | |
MA33055B1 (en) | NOVEL COMBINATION OF ACTIVE INGREDIENTS CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY AND COLCHICOSIDE DERIVATIVE | |
UY30368A1 (en) | 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA-BENZAZEPINAS, ITS PREPARATION, COMPOSITIONS THAT CONTAIN AND USE | |
CO7240380A2 (en) | Pediatric oral liquid compositions containing nepadutant | |
EA201190243A1 (en) | STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE | |
UA97076C2 (en) | Anti-inflammatory ointment based on sulfanilamide | |
MY184940A (en) | Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent | |
CL2015002906A1 (en) | Supply to the central nervous system of therapeutic agents (divisional application 3656-2012) |